282 related articles for article (PubMed ID: 32152245)
21. Metabolomic and transcriptomic signatures of influenza vaccine response in healthy young and older adults.
Chou CH; Mohanty S; Kang HA; Kong L; Avila-Pacheco J; Joshi SR; Ueda I; Devine L; Raddassi K; Pierce K; Jeanfavre S; Bullock K; Meng H; Clish C; Santori FR; Shaw AC; Xavier RJ
Aging Cell; 2022 Sep; 21(9):e13682. PubMed ID: 35996998
[TBL] [Abstract][Full Text] [Related]
22. Novel Platforms for the Development of a Universal Influenza Vaccine.
Kumar A; Meldgaard TS; Bertholet S
Front Immunol; 2018; 9():600. PubMed ID: 29628926
[TBL] [Abstract][Full Text] [Related]
23. Advances in the development of universal influenza vaccines.
Gilbert SC
Influenza Other Respir Viruses; 2013 Sep; 7(5):750-8. PubMed ID: 22998622
[TBL] [Abstract][Full Text] [Related]
24. The human antibody response to influenza A virus infection and vaccination.
Krammer F
Nat Rev Immunol; 2019 Jun; 19(6):383-397. PubMed ID: 30837674
[TBL] [Abstract][Full Text] [Related]
25. Epitope-based approaches to a universal influenza vaccine.
Gottlieb T; Ben-Yedidia T
J Autoimmun; 2014 Nov; 54():15-20. PubMed ID: 25172355
[TBL] [Abstract][Full Text] [Related]
26. Selecting and Using the Appropriate Influenza Vaccine for Each Individual.
Sekiya T; Ohno M; Nomura N; Handabile C; Shingai M; Jackson DC; Brown LE; Kida H
Viruses; 2021 May; 13(6):. PubMed ID: 34073843
[TBL] [Abstract][Full Text] [Related]
27. A multi-valent vaccine approach that elicits broad immunity within an influenza subtype.
Huber VC; Thomas PG; McCullers JA
Vaccine; 2009 Feb; 27(8):1192-200. PubMed ID: 19135117
[TBL] [Abstract][Full Text] [Related]
28. Call for a paradigm shift in the design of universal influenza vaccines by harnessing multiple correlates of protection.
Jang YH; Seong BL
Expert Opin Drug Discov; 2020 Dec; 15(12):1441-1455. PubMed ID: 32783765
[TBL] [Abstract][Full Text] [Related]
29. Systems vaccinology: its promise and challenge for HIV vaccine development.
Nakaya HI; Pulendran B
Curr Opin HIV AIDS; 2012 Jan; 7(1):24-31. PubMed ID: 22156839
[TBL] [Abstract][Full Text] [Related]
30. Strengthening the influenza vaccine virus selection and development process: Report of the 3rd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at WHO headquarters, Geneva, Switzerland, 1-3 April 2014.
Ampofo WK; Azziz-Baumgartner E; Bashir U; Cox NJ; Fasce R; Giovanni M; Grohmann G; Huang S; Katz J; Mironenko A; Mokhtari-Azad T; Sasono PM; Rahman M; Sawanpanyalert P; Siqueira M; Waddell AL; Waiboci L; Wood J; Zhang W; Ziegler T;
Vaccine; 2015 Aug; 33(36):4368-82. PubMed ID: 26148877
[TBL] [Abstract][Full Text] [Related]
31. Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity.
Chua BY; Wong CY; Mifsud EJ; Edenborough KM; Sekiya T; Tan AC; Mercuri F; Rockman S; Chen W; Turner SJ; Doherty PC; Kelso A; Brown LE; Jackson DC
mBio; 2015 Oct; 6(6):e01024-15. PubMed ID: 26507227
[TBL] [Abstract][Full Text] [Related]
32. Overcoming Barriers in the Path to a Universal Influenza Virus Vaccine.
Coughlan L; Palese P
Cell Host Microbe; 2018 Jul; 24(1):18-24. PubMed ID: 30001520
[TBL] [Abstract][Full Text] [Related]
33. M2e-based universal influenza vaccines: a historical overview and new approaches to development.
Mezhenskaya D; Isakova-Sivak I; Rudenko L
J Biomed Sci; 2019 Oct; 26(1):76. PubMed ID: 31629405
[TBL] [Abstract][Full Text] [Related]
34. Return of inactivated whole-virus vaccine for superior efficacy.
Furuya Y
Immunol Cell Biol; 2012 Jul; 90(6):571-8. PubMed ID: 21844883
[TBL] [Abstract][Full Text] [Related]
35. Epitope-focused vaccine design against influenza A and B viruses.
Ren H; Zhou P
Curr Opin Immunol; 2016 Oct; 42():83-90. PubMed ID: 27343703
[TBL] [Abstract][Full Text] [Related]
36. Influenza in temperate and tropical Asia: a review of epidemiology and vaccinology.
Young BE; Chen M
Hum Vaccin Immunother; 2020 Jul; 16(7):1659-1667. PubMed ID: 32017650
[TBL] [Abstract][Full Text] [Related]
37. Progress in the Development of Universal Influenza Vaccines.
Sun W; Luo T; Liu W; Li J
Viruses; 2020 Sep; 12(9):. PubMed ID: 32957468
[TBL] [Abstract][Full Text] [Related]
38. Insights into current clinical research on the immunogenicity of live attenuated influenza vaccines.
Isakova-Sivak I; Grigorieva E; Rudenko L
Expert Rev Vaccines; 2020 Jan; 19(1):43-55. PubMed ID: 31903816
[No Abstract] [Full Text] [Related]
39. The Human Vaccines Project: Towards a comprehensive understanding of the human immune response to immunization.
Wooden SL; Koff WC
Hum Vaccin Immunother; 2018; 14(9):2214-2216. PubMed ID: 29847214
[TBL] [Abstract][Full Text] [Related]
40. Towards a universal influenza vaccine: different approaches for one goal.
Sautto GA; Kirchenbaum GA; Ross TM
Virol J; 2018 Jan; 15(1):17. PubMed ID: 29370862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
